(Q44996588)

reason for preferred rank

8 December 2017

Retinal Toxicity in Human Immunodeficiency Virus–infected Children Treated With 2′,3′-Dideoxyinosine (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)75744-7

10 November 2022

Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)75744-7

10 November 2022

author name string

S. M. Whitcup

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

K. M. Butler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

R. Caruso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

M. D. de Smet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

B. Rubin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

R. N. Husson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

J. S. Lopez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

R. Belfort

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

P. A. Pizzo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

R. B. Nussenblatt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728133

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

8 December 2017

15 January 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728133

full work available at URL

10 November 2022

https://api.elsevier.com/content/article/PII:S0002939414757447?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0002-9394(14)75744-7

https://api.elsevier.com/content/article/PII:S0002939414757447?httpAccept=text/plain

10 November 2022

1 reference

DOI

https://api.crossref.org/works/10.1016/S0002-9394(14)75744-7

American Journal of Ophthalmology

10 November 2022

published in

1 reference

8 December 2017

113

1 reference

8 December 2017

1

1 reference

8 December 2017

1-7

1 reference

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

ddI--a good start, but still phase I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

Acquired immunodeficiency syndrome (AIDS): the disease and its ocular manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

Strategies for antiviral therapy in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

1 reference

7 January 2021

Optic neuritis associated with dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

Progressive chorioretinopathy after receiving thioridazine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

Thioridazine Pigmentary Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

Electrophysiological abnormalities in pigmentary degenerations of the retina. Assessment of value and basis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

EARLY CHLOROQUINE RETINOPATHY: CLINICAL AND FUNCTIONAL FINDINGS.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

THE EOG IN CHLOROQUINE AND OTHER RETINOPATHIES.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2975744-7

7 January 2021

Identifiers

DOI

0 references

1 reference